RHON-KLINIKUM AG Unsponsored ADR
RKAGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,595,619 | $1,463,979 | $1,446,086 | $1,591,210 |
| % Growth | 9% | 1.2% | -9.1% | – |
| Cost of Goods Sold | $1,423,797 | $1,315,166 | $446,562 | $430,395 |
| Gross Profit | $171,822 | $148,813 | $999,524 | $182,630 |
| % Margin | 10.8% | 10.2% | 69.1% | 11.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $69,400 | $70,300 | $21,700 | $20,200 |
| SG&A Expenses | $69,400 | $70,300 | $21,700 | $20,200 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $54,273 | $38,114 | $941,551 | $131,911 |
| Operating Expenses | $123,673 | $108,414 | $963,251 | $152,111 |
| Operating Income | $48,149 | $40,399 | $36,112 | $30,519 |
| % Margin | 3% | 2.8% | 2.5% | 1.9% |
| Other Income/Exp. Net | $8,055 | $7,330 | -$2,483 | -$3,158 |
| Pre-Tax Income | $56,204 | $47,729 | $33,629 | $27,361 |
| Tax Expense | $10,997 | $7,562 | $6,689 | -$2,866 |
| Net Income | $43,351 | $38,712 | $25,144 | $28,295 |
| % Margin | 2.7% | 2.6% | 1.7% | 1.8% |
| EPS | 0.34 | 0.29 | 0.19 | 0.21 |
| % Growth | 17.2% | 52.6% | -9.5% | – |
| EPS Diluted | 0.34 | 0.29 | 0.19 | 0.21 |
| Weighted Avg Shares Out | 128,771 | 133,876 | 133,876 | 133,876 |
| Weighted Avg Shares Out Dil | 128,771 | 133,876 | 133,876 | 133,876 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11,100 | $10,500 | $1,300 | $500 |
| Interest Expense | $3,400 | $3,700 | $4,100 | $3,200 |
| Depreciation & Amortization | $62,600 | $65,600 | $66,300 | $69,839 |
| EBITDA | $122,227 | $117,029 | $97,612 | $100,358 |
| % Margin | 7.7% | 8% | 6.8% | 6.3% |